Essential Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Essential Partners's BMY Position: Q2 2026 in Review
Essential Partners reduced its Bristol-Myers Squibb (BMY) stake by 5.2% in Q2 2026, selling an estimated $54.7K and leaving 17,545 shares worth $1.01M. The position accounts for 0.47% of the portfolio, ranked #31.
Essential Partners first reported a position in BMY in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.12M in Q1 2026. 2,514 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Essential Partners held 17,545 shares of Bristol-Myers Squibb worth $1.01M as of Q2 2026.
- Essential Partners sold 953 Bristol-Myers Squibb shares in Q2 2026, an estimated $54.7K.
- Bristol-Myers Squibb made up 0.47% of Essential Partners's portfolio in Q2 2026, its #31 holding.
- Essential Partners first reported a position in Bristol-Myers Squibb in Q2 2025 and has held it in 5 quarters since.
- Essential Partners's Bristol-Myers Squibb position peaked at $1.12M in Q1 2026.
- 2,514 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.